Annette O Walter

Annette O Walter

UNVERIFIED PROFILE

Are you Annette O Walter?   Register this Author

Register author
Annette O Walter

Annette O Walter

Publications by authors named "Annette O Walter"

Are you Annette O Walter?   Register this Author

6Publications

236Reads

41Profile Views

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.

Cancer Discov 2013 Dec 24;3(12):1404-15. Epub 2013 Sep 24.

1Clovis Oncology Inc., San Francisco, California; 2Celgene Avilomics Research, Bedford, Massachusetts; 3Division of Hematology-Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; 4Mouse Cancer Genetics Program; and 5Center for Advanced Preclinical Research, Science Applications International Corporation-Frederick, Inc., National Cancer Institute, Frederick, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048995PMC
December 2013

The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.

Bioorg Med Chem Lett 2010 Jan 12;20(1):157-60. Epub 2009 Nov 12.

Global Discovery Chemistry/Oncology and Exploratory Chemistry, Novartis Institutes for Biomedical Research, 5400 Hollis Street, Emeryville, CA 94608, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0960894X0901582
Publisher Site
http://dx.doi.org/10.1016/j.bmcl.2009.11.012DOI Listing
January 2010

Inhibition of Cdc7/Dbf4 kinase activity affects specific phosphorylation sites on MCM2 in cancer cells.

J Cell Biochem 2008 Jun;104(3):1075-86

Novartis Institute of Biomedical Research, Oncology, Emeryville, California 94608, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcb.21698
Publisher Site
http://dx.doi.org/10.1002/jcb.21698DOI Listing
June 2008